Searched for
REDDY S LABS
Scientists are testing a new kind of air-conditioning, and the promise is cleaner cooling without refrigerants, but the big question is whether solid-state systems can ever match the efficiency of the ACs people already useNew solid-state cooling technologies are emerging to replace traditional air conditioners. These systems aim to reduce reliance on compress...- South Park Commons backed Maya Research wants to build a voice interface that speaks like a localMaya Research is developing conversational AI models designed to speak and respond like native speakers across languages and cultural conte...
- Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Strong revenue growth fails to shield India Inc margins in March quarterCorporate India's March 2026 quarter results showed a mixed performance. While revenues grew strongly, input cost inflation and a weaker ru...
- Rising bond yields, oil prices keeping markets on edge; selective bets still emerging: Pankaj PandeyGlobal markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...
- Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
- Reddy Pharma loses 'name' in Delhi HC rulingThe Delhi High Court has ruled against Reddy Pharmaceuticals. The court upheld a decision to remove 'Reddy' from the company's name. Reddy ...
- ET Women Conclave 2026 spotlights leadership, reinvention, and powerful conversationsThe ET Women Conclave 2026 celebrated inspiring leaders, entrepreneurs, and changemakers with dialogues on authenticity, wellness, and impa...
- Dr Reddy's Laboratories Q4 Results: Cons PAT falls 86% YoY to Rs 221 crore, revenue dips 12%; Rs 8 per share dividend announcedDr Reddy's Laboratories Q4 Results: Dr. Reddy's Laboratories reported a consolidated net profit at Rs 221 crore in the March-ended quarter ...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Hyderabad laid-off techie turns 'ganja engineer' on terrace; 17 plants that could yield 10 kg seizedExcise officials in Hyderabad arrested a former software engineer for cultivating cannabis plants on his terrace. Investigators linked the ...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- VR Global Media launches $250 million capital programme, begins $120 million raiseVR Global Media has launched a $250 million capital programme to build a global entertainment platform, with an initial $120 million fundra...
- ST/BT Dr Reddy’s Labs with a target of Rs 2440: Mitesh ThackerST/BT Dr Reddy’s Labs with a target of Rs 2440 and a stop loss of Rs 2491: Mitesh Thacker.
- BT/ST Dr Reddy’s Labs with a target of Rs 2575: Mitesh ThackerBT/ST Dr Reddy’s Labs with a target of Rs 2575 and a stop loss of Rs 2514: Mitesh Thacker.
- Sell Dr Reddy’s Labs with a target of Rs 2340: Mitesh ThackerSell Dr Reddy’s Labs with a target of Rs 2340 and a stop loss of Rs 2431: Mitesh Thacker.
- Buy Dr. Reddy’s Lab with a target of 1765: Mitesh ThackerDr. Reddy’s Lab Ltd is a ‘BUY’ call with a target of Rs 1765 and a stop loss of Rs 1689.
Load More
